Nantes University Hospital: Multiple Sclerosis trials

The registry lists 14 Multiple Sclerosis studies with Nantes University Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 1Phase 3 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PRIMUS : Real World Usage for Real World Evidence of CDSS Use in Multiple SclerosisNot yet recruitingNCT07647952Not applicable
• Common and Specific Information From Neuroimaging and SmartphoneRecruitingNCT05482906
• From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple SclerosisRecruitingNCT04873492Not applicable
• Trial to Assess the Safety and Feasibility of Adoptive Cell Therapy with Autologous EBV-specific Cytotoxic T Lymphocytes (CTL) in Patients with a First Clinical Episode Highly Suggestive of Multiple SclerosisRecruitingNCT02912897Phase 1
• Peer Support Impact on Therapeutic Adherence in Patients With Multiple SclerosisActive, not recruitingNCT05519553Not applicable
• Quantifying Gait Alteration in Multiple Sclerosis Using a Wearable DeviceCompletedNCT04969848
• Comparing the Safety and Benefit of Natalizumab (Tysabri®) At-home Infusion vs At-hospital Infusion in Multiple SclerosisCompletedNCT04777539
• Wearable Biosensor to Track and Quantify Limb Dysfunction in Multiple Sclerosis PatientsCompletedNCT03369171Not applicable
• Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple SclerosisCompletedNCT03302806
• Comparison of Oral Molecules Preventing Relapses in Multiple SclerosisCompletedNCT03302442
• Re-training to Effort (RE) According to the Severity of Multiple Sclerosis: Preliminary Assessments Based on Fatigue and Quality of LifeCompletedNCT02848976
• Analyze the Myelin-TRAP as Diagnostic Tool in Multiple SclerosisTerminatedNCT01723631Not applicable
• A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).TerminatedNCT00978536Not applicable
• Safety and Efficacy of Pravastatin in Relapsing-remitting Multiple SclerosisCompletedNCT00200655Phase 3